Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gain Therapeutics, Inc. | 200,000 | reported | 24 Mar 2026 | tx 5+885,725 |
| SELLAS Life Sciences Group, Inc. | 40,000 | reported | 20 Apr 2018 | tx 1+40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Mar 2026 | GRANT_AWARD | Gain Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 20 Mar 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 06 Jan 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 271,325 | 0.00 USD | deriv |
| 09 Aug 2024 | PURCHASE | Gain Therapeutics, Inc. | 14,400 | 1.01 USD | |
| 08 Apr 2024 | GRANT_AWARD | Gain Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 20 Apr 2018 | GRANT_AWARD | SELLAS Life Sciences Group, Inc. | 40,000 | 0.00 USD | deriv |